WEE1 and acute lymphoblastic leukemia: First, to assess the sensitivity of leukemic cells that represent different ALL subtypes and lymphoid lineage differentiation states to WEE1 kinase inhibition, we treated a panel of 15 ALL cell lines with increasing concentrations of AZD1775 (Fig. 1b, refer to Additional file 1, Table S1 for GI50 data).